HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janardan P Pandey Selected Research

Immunoglobulin Allotypes (Immunoglobulin Allotype)

5/2015Endogenous antibody responsiveness to epidermal growth factor receptor is associated with immunoglobulin allotypes and overall survival of patients with glioblastoma.
2/2013The forgotten tale of immunoglobulin allotypes in cancer risk and treatment.
9/2012Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes.
6/2011Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection.
8/2008Genetic interactions of KIR and G1M immunoglobulin allotypes differ in obese from non-obese individuals with type 2 diabetes.
6/2008Immunoglobulin allotypes influence antibody responses to mucin 1 in patients with gastric cancer.
3/2008Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2.
11/2006Interaction of KIR genes and G1M immunoglobulin allotypes confer susceptibility to type 2 diabetes in Puerto Rican Americans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janardan P Pandey Research Topics

Disease

17Infections
10/2019 - 05/2004
12Neoplasms (Cancer)
01/2020 - 06/2008
9Breast Neoplasms (Breast Cancer)
08/2018 - 12/2009
6Alzheimer Disease (Alzheimer's Disease)
04/2021 - 01/2009
5Autoimmune Diseases (Autoimmune Disease)
01/2020 - 09/2002
4Neuroblastoma
01/2020 - 11/2013
4Schizophrenia (Dementia Praecox)
01/2018 - 04/2014
4Myositis (Idiopathic Inflammatory Myopathies)
03/2016 - 07/2002
4Prostatic Neoplasms (Prostate Cancer)
01/2014 - 02/2013
4Malaria
01/2013 - 12/2009
4Systemic Scleroderma (Systemic Sclerosis)
08/2005 - 11/2003
3Cognitive Dysfunction
01/2019 - 04/2014
3Dermatomyositis (Dermatopolymyositis)
03/2016 - 07/2002
3Type 2 Diabetes Mellitus (MODY)
06/2011 - 11/2006
2Virus Diseases (Viral Diseases)
01/2018 - 04/2005
2Glioma (Gliomas)
01/2014 - 01/2014
2Adenocarcinoma
08/2013 - 12/2009
2Multiple Sclerosis
01/2013 - 09/2002
2Guillain-Barre Syndrome
12/2005 - 04/2003
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
04/2005 - 06/2004
2Sarcoidosis (Schaumann Disease)
10/2003 - 06/2002
1Communicable Diseases (Infectious Diseases)
01/2022
1Cystic Fibrosis (Mucoviscidosis)
11/2021
1Chronic Hepatitis B
01/2020
1Disease Progression
01/2020
1Genetic Risk Score
01/2020
1Chills
10/2019
1Headache (Headaches)
10/2019
1Myalgia
10/2019
1Neurodevelopmental Disorders
01/2018
1Cytomegalovirus Infections (Inclusion Disease)
01/2018
1Glioblastoma (Glioblastoma Multiforme)
05/2015
1HIV Infections (HIV Infection)
06/2013
1Coinfection
01/2013
1Immunoglobulin G4-Related Disease
10/2012
1Colorectal Neoplasms (Colorectal Cancer)
09/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2011
1Hepatitis C
08/2011
1Vivax Malaria
08/2010
1Falciparum Malaria (Plasmodium falciparum Malaria)
12/2009
1Eosinophilia-Myalgia Syndrome
10/2009
1Onchocerciasis
01/2009
1Calcinosis
12/2008

Drug/Important Bio-Agent (IBA)

36Immunoglobulins (Immunoglobulin)IBA
11/2021 - 06/2002
24Immunoglobulin G (IgG)IBA
01/2020 - 05/2004
15AntibodiesIBA
01/2020 - 05/2004
14Immunoglobulin Km AllotypesIBA
11/2021 - 05/2004
13Genetic Markers (Genetic Marker)IBA
02/2019 - 12/2005
11Immunoglobulin Gm AllotypesIBA
02/2019 - 07/2007
9AntigensIBA
11/2021 - 06/2008
8Immunoglobulin Allotypes (Immunoglobulin Allotype)IBA
05/2015 - 11/2006
7DNA (Deoxyribonucleic Acid)IBA
01/2018 - 06/2002
6AutoantibodiesIBA
03/2016 - 07/2002
5Monoclonal AntibodiesIBA
01/2020 - 02/2013
5Glycoproteins (Glycoprotein)IBA
08/2018 - 10/2002
5EpitopesIBA
05/2015 - 05/2006
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2008 - 06/2002
4Proteins (Proteins, Gene)FDA Link
08/2018 - 05/2004
4Mucin-1 (CA 15-3 Antigen)IBA
01/2018 - 06/2008
3KIR ReceptorsIBA
02/2019 - 08/2008
3Glutens (Glutelin)IBA
10/2016 - 04/2014
3ErbB Receptors (EGF Receptor)IBA
05/2015 - 02/2013
3CytokinesIBA
12/2008 - 09/2002
3Lymphotoxin-alpha (Lymphotoxin)IBA
06/2004 - 09/2002
2Broadly Neutralizing AntibodiesIBA
01/2022 - 12/2015
2HLA Antigens (Human Leukocyte Antigens)IBA
04/2021 - 02/2019
2ApolipoproteinsIBA
12/2020 - 01/2020
2LigandsIBA
01/2020 - 01/2018
2VaccinesIBA
01/2018 - 08/2010
2Tryptophan (L-Tryptophan)FDA Link
10/2016 - 10/2009
2EnzymesIBA
03/2016 - 08/2005
2CTLA-4 AntigenIBA
04/2005 - 01/2004
1Apolipoproteins E (ApoE)IBA
01/2020
1Amyloid beta-PeptidesIBA
01/2020
1Panitumumab (Vectibix)FDA Link
01/2020
1dinutuximabIBA
01/2020
1Viral ProteinsIBA
01/2018
1KynurenineIBA
10/2016
1Simplexvirus glycoprotein BIBA
02/2016
1epidermal growth factor receptor VIIIIBA
05/2015
1Phenylalanine (L-Phenylalanine)FDA Link
05/2014
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2014
1Valine (L-Valine)FDA Link
01/2014
1AllergensIBA
12/2013
1Histidine (L-Histidine)FDA Link
12/2013
1AIDS VaccinesIBA
06/2013
1Fc Receptors (Fc Receptor)IBA
02/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013
1Cyclin B1IBA
02/2013
1Neoplasm Antigens (Tumor Antigens)IBA
11/2012
1Cetuximab (Erbitux)FDA Link
09/2012
1Biomarkers (Surrogate Marker)IBA
12/2011
1hemoglobin AAIBA
10/2011
1Pharmaceutical PreparationsIBA
06/2011
1human ERBB2 proteinIBA
11/2010
1Immunoglobulin kappa-Chains (kappa-Chain, Immunoglobulin)IBA
01/2009

Therapy/Procedure

5Immunotherapy
02/2016 - 11/2010
4Therapeutics
01/2020 - 08/2011
1Intravenous Administration
10/2019
1Transplantation
01/2018